Adjusting MtDNA Quantification in Whole Blood for Peripheral Blood Platelet and Leukocyte Counts.
Alterations of mitochondrial DNA copy number (mtDNAcn) in the blood (mitochondrial to nuclear DNA ratio) appear associated with several systemic diseases, including primary mitochondrial disorders, carcinogenesis, and hematologic diseases. Measuring mtDNAcn in DNA extracted from whole blood (WB) ins...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5063275?pdf=render |
_version_ | 1819030260944994304 |
---|---|
author | Yamilee Hurtado-Roca Marta Ledesma Monica Gonzalez-Lazaro Raquel Moreno-Loshuertos Patricio Fernandez-Silva Jose Antonio Enriquez Martin Laclaustra |
author_facet | Yamilee Hurtado-Roca Marta Ledesma Monica Gonzalez-Lazaro Raquel Moreno-Loshuertos Patricio Fernandez-Silva Jose Antonio Enriquez Martin Laclaustra |
author_sort | Yamilee Hurtado-Roca |
collection | DOAJ |
description | Alterations of mitochondrial DNA copy number (mtDNAcn) in the blood (mitochondrial to nuclear DNA ratio) appear associated with several systemic diseases, including primary mitochondrial disorders, carcinogenesis, and hematologic diseases. Measuring mtDNAcn in DNA extracted from whole blood (WB) instead of from peripheral blood mononuclear cells or buffy coat may yield different results due to mitochondrial DNA present in platelets. The aim of this work is to quantify the contribution of platelets to mtDNAcn in whole blood [mtDNAcn(WB)] and to propose a correction formula to estimate leukocytes' mtDNAcn [mtDNAcn(L)] from mtDNAcn(WB). Blood samples from 10 healthy adults were combined with platelet-enriched plasma and saline solution to produce artificial blood preparations. Aliquots of each sample were combined with five different platelet concentrations. In 46 of these blood preparations, mtDNAcn was measured by qPCR. MtDNAcn(WB) increased 1.07 (95%CI 0.86, 1.29; p<0.001) per 1000 platelets present in the preparation. We proved that leukocyte count should also be taken into account as mtDNAcn(WB) was inversely associated with leukocyte count; it increased 1.10 (95%CI 0.95, 1.25, p<0.001) per unit increase of the ratio between platelet and leukocyte counts. If hematological measurements are available, subtracting 1.10 the platelets/leukocyte ratio from mtDNAcn(WB) may serve as an estimation for mtDNAcn(L). Both platelet and leukocyte counts in the sample are important sources of variation if comparing mtDNAcn among groups of patients when mtDNAcn is measured in DNA extracted from whole blood. Not taking the platelet/leukocyte ratio into account in whole blood measurements, may lead to overestimation and misclassification if interpreted as leukocytes' mtDNAcn. |
first_indexed | 2024-12-21T06:27:20Z |
format | Article |
id | doaj.art-d8fdc3ce704c49458779eb94415aa5ed |
institution | Directory Open Access Journal |
issn | 1932-6203 |
language | English |
last_indexed | 2024-12-21T06:27:20Z |
publishDate | 2016-01-01 |
publisher | Public Library of Science (PLoS) |
record_format | Article |
series | PLoS ONE |
spelling | doaj.art-d8fdc3ce704c49458779eb94415aa5ed2022-12-21T19:13:05ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-011110e016377010.1371/journal.pone.0163770Adjusting MtDNA Quantification in Whole Blood for Peripheral Blood Platelet and Leukocyte Counts.Yamilee Hurtado-RocaMarta LedesmaMonica Gonzalez-LazaroRaquel Moreno-LoshuertosPatricio Fernandez-SilvaJose Antonio EnriquezMartin LaclaustraAlterations of mitochondrial DNA copy number (mtDNAcn) in the blood (mitochondrial to nuclear DNA ratio) appear associated with several systemic diseases, including primary mitochondrial disorders, carcinogenesis, and hematologic diseases. Measuring mtDNAcn in DNA extracted from whole blood (WB) instead of from peripheral blood mononuclear cells or buffy coat may yield different results due to mitochondrial DNA present in platelets. The aim of this work is to quantify the contribution of platelets to mtDNAcn in whole blood [mtDNAcn(WB)] and to propose a correction formula to estimate leukocytes' mtDNAcn [mtDNAcn(L)] from mtDNAcn(WB). Blood samples from 10 healthy adults were combined with platelet-enriched plasma and saline solution to produce artificial blood preparations. Aliquots of each sample were combined with five different platelet concentrations. In 46 of these blood preparations, mtDNAcn was measured by qPCR. MtDNAcn(WB) increased 1.07 (95%CI 0.86, 1.29; p<0.001) per 1000 platelets present in the preparation. We proved that leukocyte count should also be taken into account as mtDNAcn(WB) was inversely associated with leukocyte count; it increased 1.10 (95%CI 0.95, 1.25, p<0.001) per unit increase of the ratio between platelet and leukocyte counts. If hematological measurements are available, subtracting 1.10 the platelets/leukocyte ratio from mtDNAcn(WB) may serve as an estimation for mtDNAcn(L). Both platelet and leukocyte counts in the sample are important sources of variation if comparing mtDNAcn among groups of patients when mtDNAcn is measured in DNA extracted from whole blood. Not taking the platelet/leukocyte ratio into account in whole blood measurements, may lead to overestimation and misclassification if interpreted as leukocytes' mtDNAcn.http://europepmc.org/articles/PMC5063275?pdf=render |
spellingShingle | Yamilee Hurtado-Roca Marta Ledesma Monica Gonzalez-Lazaro Raquel Moreno-Loshuertos Patricio Fernandez-Silva Jose Antonio Enriquez Martin Laclaustra Adjusting MtDNA Quantification in Whole Blood for Peripheral Blood Platelet and Leukocyte Counts. PLoS ONE |
title | Adjusting MtDNA Quantification in Whole Blood for Peripheral Blood Platelet and Leukocyte Counts. |
title_full | Adjusting MtDNA Quantification in Whole Blood for Peripheral Blood Platelet and Leukocyte Counts. |
title_fullStr | Adjusting MtDNA Quantification in Whole Blood for Peripheral Blood Platelet and Leukocyte Counts. |
title_full_unstemmed | Adjusting MtDNA Quantification in Whole Blood for Peripheral Blood Platelet and Leukocyte Counts. |
title_short | Adjusting MtDNA Quantification in Whole Blood for Peripheral Blood Platelet and Leukocyte Counts. |
title_sort | adjusting mtdna quantification in whole blood for peripheral blood platelet and leukocyte counts |
url | http://europepmc.org/articles/PMC5063275?pdf=render |
work_keys_str_mv | AT yamileehurtadoroca adjustingmtdnaquantificationinwholebloodforperipheralbloodplateletandleukocytecounts AT martaledesma adjustingmtdnaquantificationinwholebloodforperipheralbloodplateletandleukocytecounts AT monicagonzalezlazaro adjustingmtdnaquantificationinwholebloodforperipheralbloodplateletandleukocytecounts AT raquelmorenoloshuertos adjustingmtdnaquantificationinwholebloodforperipheralbloodplateletandleukocytecounts AT patriciofernandezsilva adjustingmtdnaquantificationinwholebloodforperipheralbloodplateletandleukocytecounts AT joseantonioenriquez adjustingmtdnaquantificationinwholebloodforperipheralbloodplateletandleukocytecounts AT martinlaclaustra adjustingmtdnaquantificationinwholebloodforperipheralbloodplateletandleukocytecounts |